However, validation of the results in two independent, largely different populations from South and Northern/Center Italy supports a general involvement of GCKR rs780094 C>T polymorphisms in NAFLD progression. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.